Fellowship · Kansas City, MO
Sponsored by University of Missouri-Kansas City School of Medicine
Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I-III Triple-negative Breast Cancer (NeoSTOP).
Clinical cancer research : an official journal of the American Association for Cancer Research · 2021 · 92 citations · Sheshadri Madhusudhana, Anuj Shrestha
Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer.
NPJ breast cancer · 2022 · 67 citations · Sheshadri Madhusudhana, Anuj Shrestha
Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia.
Journal of hematology & oncology · 2023 · 41 citations · Waled Bahaj
Molecular patterns identify distinct subclasses of myeloid neoplasia.
Nature communications · 2023 · 36 citations · Waled Bahaj
A review on disease modifying pharmacologic therapies for sickle cell disease.
Annals of hematology · 2025 · 10 citations · Anuj Shrestha
Validation of the Molecular International Prognostic Scoring System in patients with myelodysplastic syndromes.
Blood · 2023 · 25 citations · Waled Bahaj
Splenectomy outcomes in immune cytopenias: Treatment outcomes and determinants of response.
Journal of internal medicine · 2024 · 8 citations · Waled Bahaj
Genomics of deletion 7 and 7q in myeloid neoplasm: from pathogenic culprits to potential synthetic lethal therapeutic targets.
Leukemia · 2023 · 22 citations · Waled Bahaj